• 2021
  Devi-Marulkar P, Moraes-Cabe C, Campagne P, Corre B, Meghraoui-Kheddar A, Bondet V, Llibre A, Duffy D, Maillart E, Papeix C, Pellegrini S, Michel F, , Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment., Front Immunol 2021 ; 12(): 628375.
• 2019
  Azébi S, Batsché E, Michel F, Kornobis E, Muchardt C, Expression of endogenous retroviruses reflects increased usage of atypical enhancers in T cells, EMBO J. 2019 May;.
• 2017
  Govender U, Corre B, Bourdache Y, Pellegrini S, Michel F, Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors, J. Leukoc. Biol. 2017 05;101(5):1181-1190.
• 2013
  Corre B, Perrier J, El Khouri M, Cerboni S, Pellegrini S, Michel F, Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4⁺ T cells, Eur. J. Immunol. 2013 Oct;43(10):2730-40.
• 2013
  Li Z, Gakovic M, Ragimbeau J, Eloranta ML, Rönnblom L, Michel F, Pellegrini S, Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent, J. Immunol. 2013 Mar;190(5):2335-44.
• 2010
  Dong S, Corre B, Nika K, Pellegrini S, Michel F, T cell receptor signal initiation induced by low-grade stimulation requires the cooperation of LAT in human T cells, PLoS ONE 2010;5(11):e15114.
• 2006
  Dong S, Corre B, Foulon E, Dufour E, Veillette A, Acuto O, Michel F, T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2, J. Exp. Med. 2006 Oct;203(11):2509-18.
• 2005
  Rohrlich PS, Fazilleau N, Ginhoux F, Firat H, Michel F, Cochet M, Laham N, Roth MP, Pascolo S, Nato F, Coppin H, Charneau P, Danos O, Acuto O, Ehrlich R, Kanellopoulos J, Lemonnier FA, Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function, Proc. Natl. Acad. Sci. U.S.A. 2005 Sep;102(36):12855-60.
• 2003
  Acuto O, Michel F, CD28-mediated co-stimulation: a quantitative support for TCR signalling, Nat. Rev. Immunol. 2003 Dec;3(12):939-51.
• 2003
  Acuto O, Mise-Omata S, Mangino G, Michel F, Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor, Immunol. Rev. 2003 Apr;192:21-31.
• 2002
  Irles C, Symons A, Michel F, Bakker TR, van der Merwe PA, Acuto O, CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling, Nat. Immunol. 2003 Feb;4(2):189-97.
• 2002
  Michel F, Acuto O, CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?, Sci. STKE 2002 Aug;2002(144):pe35.